Financial Instruments (Tables)

12 Months Ended

Dec. 30, 2023

Investments, All Other Investments [Abstract]

Schedule of Fair Values of Derivative Instruments Included within Accompanying Consolidated Balance Sheets

The fair values of derivative instruments included within the accompanying Consolidated Balance Sheets as of 2023 and 2022 year end are as follows:

		2023				2022
(Amounts in millions)	Balance Sheet Presentation	Derivative Assets Fair Value		Derivative Liability Fair Value		Derivative Assets Fair Value		Derivative Liability Fair Value
Derivatives not designated as hedging instruments:
Foreign currency forwards	Prepaid expenses and other current assets	$	17.9	$	—	$	18.5	$	—
Foreign currency forwards	Other accrued liabilities	—		11.9		—		16.9
Equity forwards	Prepaid expenses and other current assets	19.9		—		14.8		—
Total derivative instruments		$	37.8	$	11.9	$	33.3	$	16.9

Schedule of Effect of Derivative Instruments Designated as Fair Value and Cash Flow Hedges Included in the Consolidated Statements of Earnings

The effect of derivative instruments designated as fair value and cash flow hedges as included in the Consolidated Statements of Earnings is as follows: 

	Gain (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships
	2023				2022				2021
(Amounts in millions)	Interest expense		Other income (expense) – net		Interest expense		Other income (expense) – net		Interest expense		Other income (expense) – net
Total amounts of income and expense presented in the Consolidated Statements of Earnings:	$	(49.9)	$	67.5	$	(47.1)	$	42.5	$	(53.1)	$	16.5
Gain (loss) on fair value hedging relationships:
Interest rate swaps
Long-term debt	$	—	$	—	$	—	$	—	$	(10.2)	$	—
Derivatives designated as hedging instruments	—		—		—		—		2.7		—
Gain on cash flow hedging relationships:
Treasury locks
Gain reclassified from accumulated OCI into income	$	1.6	$	—	$	1.6	$	—	$	1.6	$	—

Schedule of Derivative Instruments Not Designated as Hedges Included in Consolidated Statements of Earnings

The effects of derivative instruments not designated as hedging instruments as included in the Consolidated Statements of Earnings are as follows: 

	Statement of Earnings Presentation	Gain (Loss) Recognized in Income on Derivatives
(Amounts in millions)		2023		2022		2021
Gain (loss) on derivative relationships:
Foreign currency forwards	Other income   (expense) –  net	$	6.0	$	(17.6)	$	(10.8)
Net exposures	Other income   (expense) –  net	(17.0)		10.1		9.6
Equity forwards	Operating expenses	$	4.5	$	1.4	$	4.1
Stock-based deferred compensation liabilities	Operating expenses	(4.5)		(1.4)		(4.3)

Schedule of Fair Values of Financial Instruments Not Approximating Carrying Values in Financial Statements

The fair values of financial instruments that do not approximate the carrying values in the financial statements as of 2023 and 2022 year end are as follows: 

	2023				2022
(Amounts in millions)	Carrying Value		Fair Value		Carrying Value		Fair Value
Finance receivables – net	$	1,878.3	$	2,138.7	$	1,733.0	$	1,983.9
Contract receivables – net	528.7		561.6		493.7		520.4
Long-term debt and notes payable	1,200.2		1,031.5		1,201.0		982.1